Asst. Prof. at McGill University | Abdominal & GU Imaging
Montréal, Québec
Joined September 2019
- Tweets68
- Following168
- Followers81
- Likes618
Dominik Deniffel, MD retweeted
Study examines the path to proficiency in prostate MRI interpretation for trainees. @ddeniffel @TU_Muenchen & @trwherrmann join @zklaassen_md @GACancerCenter to discuss learning benchmarks for prostate MRI interpretation from 14 MRI-naive trainees reading 200 multiparametric MRI cases. #WatchNow > bit.ly/4sPIhww
Dominik Deniffel, MD retweeted
⚠️💣PI-QUAL v2 is finally out! link.springer.com/article/10…
Great teamwork with @MaartendeRooij and an outstanding panel of international experts! Let’s work together to improve prostate MR image quality across the 🌎🌍🌏! @EurRadiology @EsurOffice @myESR @ESUR_JN
Dominik Deniffel, MD retweeted
academic.oup.com/bjr/advance…
🌰The prostate is often largest in craniocaudal diameter 👉 so are many high grade tumors.
🛑It's easier to grow within the organ than beyond it.
🏔️Don't neglect the CC diameter of tumors
Dominik Deniffel, MD retweeted
VI-RADS is the strongest predictor of MIBC response to neoadjuvant immunotherapy. Different VI-RADS scores have distinctive biomarker features.
bjui-journals.onlinelibrary.…
Great teamwork! @AndreaNecchi @FDeCobelli
🩻 Happy to share our multidisciplinary effort on VI‐RADS use predicting the outcome of neoadjuvant pembrolizumab in MIBC #PURE01 @GiorgioBre @CMercinelli @Anto_cigliola @ewanagibb @giannatempopatr @DanieleRaggi83 @BasileG_ @MyUniSR @SanRaffaeleMI bjui-journals.onlinelibrary.…
Dominik Deniffel, MD retweeted
MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension - ScienceDirect sciencedirect.com/science/ar…
Dominik Deniffel, MD retweeted
Really nice article by the PRECISE team! A lot of food for thought and deserves a thorough read by anyone who reads prostate MRI for active surveillance.
New @AJR_Radiology Accepted Manuscript:
"The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review"
By Drs Sanmugalingam, @Tristan_Radiol, & team @CUH_NHS
ajronline.org/doi/10.2214/AJ…
Dominik Deniffel, MD retweeted
Improvement in post-operative recurrence #risk assessment when adding CT-based #radiomic features to established prognostic biomarkers. (@ddeniffel et al.)
🔗 buff.ly/3L7LVNB
#EuropeanRadiology
1/ Thrilled to announce that our latest paper is now published in @EurRadiology. We showed that adding #radiomics to clinical variables can improve recurrence risk assessment for non-metastatic #RCC.
Full article⬇️
doi.org/10.1007/s00330-023-0…
@imagingtoronto @uofturology @ESUR_JN
2/ Our decision curve analysis showed a combined model (4 radiomic + 4 clinical variables) improved adjuvant treatment decisions over a clinical base model. However, radiomics' added clinical value was relatively small (potential for deep learning?).
3/ Huge thanks to Masoom Haider @radfiler for leading this work and to all amazing co-authors for their contributions: @_kmcalpine @urooncmd @lawson6keith @ger_healy @emmanuel7s @TheoKwast. We hope our findings will help advance personalized treatment for RCC patients.
Dominik Deniffel, MD retweeted
Ladies and Gentleman, four world-class GU pathologists making a cogent argument for renaming GG1/G6
"Acinar neoplasm" anyone?
@GladellPaner @dr_coops @urogeek @aleberlin2 @VickersBiostats @adamkibel_uro @mleapman
pubmed.ncbi.nlm.nih.gov/3707…
Dominik Deniffel, MD retweeted
📚 This study developed and compared strategies to identify patients who may forgo concurrent systematic #biopsy in favor of MRI-targeted alone.
Would you like to read more?
Click the link below 👇
buff.ly/3ZhNFc7
#Radiology #Medicine #Imaging
Attention all Uroradiology enthusiasts! Join me at #ECR2023 for my presentation on using radiomics for adjuvant treatment decisions in non-metastatic RCC. @ESUR_JN @renatocuocolo @imagingtoronto
Dominik Deniffel, MD retweeted
Common practice & recommended in several papers is to biopsy man with -ve MRI if PSA density > 0.15. But where did this cut-point come from (brief answer: a pretty random paper in the pre-MRI era) and is it rational (brief answer: no)? doi.org/10.1016/j.euf.2022.1…
Dominik Deniffel, MD retweeted
Research fellow Emmanuel Miranda @emmanuel7s in the @radfiler Haider lab recently validated a non-invasive radiogenomic biomarker in pancreatic cancer, which could be used to personalize neoadjuvant treatment @ESR_Journals ⬇️
link.springer.com/article/10…
Dominik Deniffel, MD retweeted
Good morning to everyone except people who repeat their whole 'Findings' section in the 'Impression'
Dominik Deniffel, MD retweeted
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men pubs.rsna.org/doi/10.1148/ra… #ProstateCancer #medtwitter #CancerResearch
Dominik Deniffel, MD retweeted
Radiology’s impact factor increased from 11.1 to 29.1 in 2021. Impact factor measures the relevance and influence of academic journals based on citation data. Thanks to our authors, reviewers, and editors who helped Radiology maintain its role as the leading radiology journal!
Dominik Deniffel, MD retweeted
I don’t understand this. Would we say “colon polyp not cancer don’t treat”? Or what about prophylactic mastectomy for BRCA? Treat if reduction in risk > harm. Nothing to do with what we call the lesion.
